Teehan Brendan has filed 54 insider transactions across 2 companies since January 2022.
Most recent transaction: a grant/award of 51714 shares of Pacira BioSciences, Inc. ($PCRX) on February 11, 2026.
Activity breakdown: 0 open-market purchases and 13 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Pacira BioSciences, Inc. | $PCRX | Teehan Brendan | Chief Commercial Officer | A | Common Stock | 51714 | $0.00 | 100,934.2680 | 45,729,000 | 105.07% | 0.11% |
| Jan. 30, 2026 | Pacira BioSciences, Inc. | $PCRX | Teehan Brendan | Chief Commercial Officer | F | Common Stock | 5182 | $20.54 | 49,220.2680 | 45,729,000 | 9.53% | 0.01% |
| Dec. 31, 2025 | Pacira BioSciences, Inc. | $PCRX | Teehan Brendan | Chief Commercial Officer | A | Common Stock | 402 | $10.76 | 54,402.2680 | 45,729,000 | 0.74% | 0.00% |
| Feb. 1, 2025 | Pacira BioSciences, Inc. | $PCRX | Teehan Brendan | Chief Commercial Officer | A | Common Stock | 54000 | $0.00 | 54,000.0000 | 46,245,000 | 9999.99% | 0.12% |
| Feb. 4, 2025 | Pacira BioSciences, Inc. | $PCRX | Teehan Brendan | Chief Commercial Officer | A | Stock Option (Right to Buy) | 99500 | $26.59 | 99,500.0000 | 46,245,000 | 9999.99% | 0.22% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Common Stock | 9913 | $0.00 | 72,434.0000 | 166,178,000 | 15.86% | 0.01% |
| Nov. 19, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S | Common Stock | 10329 | $16.81 | 62,105.0000 | 166,178,000 | 14.26% | 0.01% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Restricted Stock Units | 9913 | $0.00 | 9,913.0000 | 166,178,000 | 50.00% | 0.01% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Restricted Stock Units | 9913 | $0.00 | 9,913.0000 | 166,178,000 | 50.00% | 0.01% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Common Stock | 9913 | $0.00 | 62,521.0000 | 166,178,000 | 18.84% | 0.01% |
| Aug. 19, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S | Common Stock | 9534 | $15.28 | 52,177.0000 | 163,819,000 | 15.45% | 0.01% |
| Aug. 16, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A | Common Stock | 5024 | $0.00 | 48,082.0000 | 163,819,000 | 11.67% | 0.00% |
| Aug. 16, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A | Common Stock | 13629 | $0.00 | 61,711.0000 | 163,819,000 | 28.35% | 0.01% |
| May 1, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Common Stock | 6814 | $0.00 | 45,610.0000 | 163,819,000 | 17.56% | 0.00% |
| May 2, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S | Common Stock | 3477 | $16.94 | 42,133.0000 | 163,819,000 | 7.62% | 0.00% |
| May 1, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Restricted Stock Units | 6814 | $0.00 | 20,445.0000 | 163,819,000 | 25.00% | 0.00% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Common Stock | 5024 | $0.00 | 41,364.0000 | 163,819,000 | 13.82% | 0.00% |
| April 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S | Common Stock | 2568 | $17.87 | 38,796.0000 | 163,819,000 | 6.21% | 0.00% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Restricted Stock Units | 5024 | $0.00 | 10,048.0000 | 163,819,000 | 33.33% | 0.00% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A | Restricted Stock Units | 27460 | $0.00 | 27,460.0000 | 163,819,000 | 9999.99% | 0.02% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A | Common Stock | 10048 | $0.00 | 41,480.0000 | 163,819,000 | 31.97% | 0.01% |
| March 27, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S | Common Stock | 5140 | $17.90 | 36,340.0000 | 163,819,000 | 12.39% | 0.00% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | A | Stock Options (Right to Buy) | 89516 | $0.00 | 89,516.0000 | 163,819,000 | 9999.99% | 0.05% |
| Feb. 23, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Restricted Stock Units | 1107 | $0.00 | 1,107.0000 | 163,819,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | S | Common Stock | 624 | $24.67 | 31,432.0000 | 163,819,000 | 1.95% | 0.00% |
| Feb. 23, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | M | Common Stock | 1107 | $0.00 | 32,056.0000 | 163,819,000 | 3.58% | 0.00% |
| Jan. 6, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 1287 | $0.00 | 31,680.0000 | 163,819,000 | 4.23% | 0.00% |
| Jan. 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 731 | $29.96 | 30,949.0000 | 163,819,000 | 2.31% | 0.00% |
| Jan. 6, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 1287 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 4956 | $0.00 | 35,353.0000 | 161,683,000 | 16.30% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 4956 | $0.00 | 30,397.0000 | 161,683,000 | 19.48% | 0.00% |
| Nov. 20, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 4960 | $22.64 | 30,393.0000 | 161,683,000 | 14.03% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 4956 | $0.00 | 19,826.0000 | 161,683,000 | 20.00% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 4956 | $0.00 | 19,826.0000 | 161,683,000 | 20.00% | 0.00% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 14869 | $0.00 | 24,782.0000 | 161,683,000 | 37.50% | 0.01% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 14869 | $0.00 | 24,782.0000 | 161,683,000 | 37.50% | 0.01% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 14869 | $22.50 | 24,356.0000 | 161,683,000 | 37.91% | 0.01% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 14869 | $0.00 | 39,225.0000 | 161,683,000 | 61.05% | 0.01% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 14869 | $0.00 | 24,356.0000 | 161,683,000 | 156.73% | 0.01% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | A | Restricted Stock Units | 27259 | $0.00 | 27,259.0000 | 161,683,000 | 9999.99% | 0.02% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | A | Stock Options (Right to Buy) | 89936 | $0.00 | 89,936.0000 | 161,683,000 | 9999.99% | 0.06% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 548 | $21.18 | 9,487.0000 | 161,683,000 | 5.46% | 0.00% |
| April 29, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 1567 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.00% |
| April 29, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 1567 | $0.00 | 10,035.0000 | 161,683,000 | 18.50% | 0.00% |
| April 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 5024 | $0.00 | 15,072.0000 | 161,683,000 | 25.00% | 0.00% |
| April 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 5024 | $0.00 | 10,219.0000 | 161,683,000 | 96.71% | 0.00% |
| April 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 1751 | $18.16 | 8,468.0000 | 161,683,000 | 17.13% | 0.00% |
| Feb. 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 1107 | $0.00 | 5,656.0000 | 161,683,000 | 24.34% | 0.00% |
| Feb. 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 461 | $18.78 | 5,195.0000 | 161,683,000 | 8.15% | 0.00% |
| Feb. 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 1107 | $0.00 | 2,214.0000 | 161,683,000 | 33.33% | 0.00% |
| Jan. 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 1286 | $0.00 | 1,287.0000 | 161,683,000 | 49.98% | 0.00% |
| Jan. 6, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Restricted Stock Units | 1286 | $0.00 | 2,573.0000 | 0 | 33.32% | 0.00% |
| Jan. 9, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S | Common Stock | 532 | $17.13 | 4,549.0000 | 161,683,000 | 10.47% | 0.00% |
| Jan. 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M | Common Stock | 1286 | $0.00 | 5,081.0000 | 161,683,000 | 33.89% | 0.00% |